News & Perspective

Jan 15, 2009

Jan 15, 2009

Novartis gets US contract for cell-based flu vaccine plant

(CIDRAP News) – The US government has awarded Novartis a $487 million contract to help build a plant in North Carolina that the company says will be capable of producing 150 million doses of cell-based pandemic influenza vaccine within 6 months after the start of a pandemic.